Real-time enrollment status for this recurrent adult t-cell leukemia/lymphoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:45 PM UTC
| NCT Number | NCT04848064 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Adult T-Cell Leukemia/Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | John Reneau |
| Last Updated on CT.gov | February 10, 2026 (Feb 10, 2026) |
As of July 19, 2026: Clinical trial NCT04848064 is currently recruiting participants. This phase1 study for recurrent adult t-cell leukemia/lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by John Reneau. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04848064 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04848064 was last updated Feb 10, 2026 (February 10, 2026). HelloStudys verifies this status automatically.